Other Species / Isoforms
  MAD1L1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T8-p
MEDLGENtMVLstLR
Upstream
1 1
Kinase, in vitro:
  • TTK (human)
MAD1L1 (human) MEDLGENtMVLstLR T8-p
MAD1L1 (mouse) MEDLGENTTVLSSLR T8
MAD1L1 (rat) MEDLGENTTVLSTLR T8
S12-p
GENtMVLstLRsLNN
0 2
MAD1L1 (human) GENtMVLstLRsLNN S12-p
MAD1L1 (mouse) GENTTVLSSLRSLNN S12
MAD1L1 (rat) GENTTVLSTLRSLNN S12
T13-p
ENtMVLstLRsLNNF
Upstream
0 1
Treatment
  • hesperadin
  • MG132
  • nocodazole
MAD1L1 (human) ENtMVLstLRsLNNF T13-p
MAD1L1 (mouse) ENTTVLSSLRSLNNF S13
MAD1L1 (rat) ENTTVLSTLRSLNNF T13
S16-p
MVLstLRsLNNFIsQ
0 8
MAD1L1 (human) MVLstLRsLNNFIsQ S16-p
MAD1L1 (mouse) TVLSSLRSLNNFISQ S16
MAD1L1 (rat) TVLSTLRSLNNFISQ S16
S22-p
RsLNNFIsQRVEGGs
Upstream
2 2
Kinase, in vitro:
  • TTK (human)
Putative in vivo kinases:
  • PLK1 (human)
MAD1L1 (human) RsLNNFIsQRVEGGs S22-p
MAD1L1 (mouse) RSLNNFISQRMEGTS S22
MAD1L1 (rat) RSLNNFISQRMEGAS S22
S29-p
sQRVEGGsGLDISTS
Upstream
1 1
Putative in vivo kinases:
  • PLK1 (human)
MAD1L1 (human) sQRVEGGsGLDISTS S29-p
MAD1L1 (mouse) SQRMEGTSGLDVSTS S29
MAD1L1 (rat) SQRMEGASGLDVSTS S29
K61-ac
RAEQIRSksHLIQVE
0 2
MAD1L1 (human) RAEQIRSksHLIQVE K61-ac
MAD1L1 (mouse) RAEQIRSkSYLIQVE K61-ac
MAD1L1 (rat) RAEQIRSKSYLIQVE K61
K61-ub
RAEQIRSksHLIQVE
0 3
MAD1L1 (human) RAEQIRSksHLIQVE K61-ub
MAD1L1 (mouse) RAEQIRSKSYLIQVE K61
MAD1L1 (rat) RAEQIRSKSYLIQVE K61
K61-sm
RAEQIRSksHLIQVE
0 1
MAD1L1 (human) RAEQIRSksHLIQVE K61-sm
MAD1L1 (mouse) RAEQIRSKSYLIQVE K61
MAD1L1 (rat) RAEQIRSKSYLIQVE K61
S62-p
AEQIRSksHLIQVER
Upstream
1 0
Kinase, in vitro:
  • TTK (human)
MAD1L1 (human) AEQIRSksHLIQVER S62-p
MAD1L1 (mouse) AEQIRSkSYLIQVER S62
MAD1L1 (rat) AEQIRSKSYLIQVER S62
S77-p
EKMQMELsHkRARVE
0 3
MAD1L1 (human) EKMQMELsHkRARVE S77-p
MAD1L1 (mouse) EKMQMELsHKRARVE S77-p
MAD1L1 (rat) EKMQMELSHKRARVE S77
K79-ub
MQMELsHkRARVELE
0 2
MAD1L1 (human) MQMELsHkRARVELE K79-ub
MAD1L1 (mouse) MQMELsHKRARVELE K79
MAD1L1 (rat) MQMELSHKRARVELE K79
S90-p
VELERAAstsARNyE
0 2
MAD1L1 (human) VELERAAstsARNyE S90-p
MAD1L1 (mouse) VELERAASTNARNYE S90
MAD1L1 (rat) VELERAASTNARNYE S90
T91-p
ELERAAstsARNyER
0 1
MAD1L1 (human) ELERAAstsARNyER T91-p
MAD1L1 (mouse) ELERAASTNARNYER T91
MAD1L1 (rat) ELERAASTNARNYER T91
S92-p
LERAAstsARNyERE
0 2
MAD1L1 (human) LERAAstsARNyERE S92-p
MAD1L1 (mouse) LERAASTNARNYERE N92
MAD1L1 (rat) LERAASTNARNYERE N92
Y96-p
AstsARNyEREVDRN
0 1
MAD1L1 (human) AstsARNyEREVDRN Y96-p
MAD1L1 (mouse) ASTNARNYEREVDRN Y96
MAD1L1 (rat) ASTNARNYEREVDRN Y96
K123-ub
REAGAEEkMQEQLER
0 1
MAD1L1 (human) REAGAEEkMQEQLER K123-ub
MAD1L1 (mouse) CEATAEEKMREQLER K123
MAD1L1 (rat) REAAAEEKMREQLER K123
K143-ac
QNLDAASkRLREkED
0 1
MAD1L1 (human) QNLDAASkRLREkED K143-ac
MAD1L1 (mouse) QNLDAVSQQLREQED Q143
MAD1L1 (rat) QSLDAASQQLRERED Q143
K143-ub
QNLDAASkRLREkED
0 3
MAD1L1 (human) QNLDAASkRLREkED K143-ub
MAD1L1 (mouse) QNLDAVSQQLREQED Q143
MAD1L1 (rat) QSLDAASQQLRERED Q143
K148-ub
ASkRLREkEDSLAQA
0 1
MAD1L1 (human) ASkRLREkEDSLAQA K148-ub
MAD1L1 (mouse) VSQQLREQEDSLASA Q148
MAD1L1 (rat) ASQQLREREDGLAAA R148
K163-ub
GETINALkGRISELQ
0 1
MAD1L1 (human) GETINALkGRISELQ K163-ub
MAD1L1 (mouse) REMISSLKGRVSELQ K163
MAD1L1 (rat) RETISSLKGRVSELQ K163
S185-p
MRVKRLEsEKQELQE
0 1
MAD1L1 (human) MRVKRLEsEKQELQE S185-p
MAD1L1 (mouse) VQVKRLESEKQELKE S185
MAD1L1 (rat) VQVKRLESEKQELKE S185
K207-ub
KCQEANQkIQELQAs
0 1
MAD1L1 (human) KCQEANQkIQELQAs K207-ub
MAD1L1 (mouse) KWQEANQKIQELQAS K207
MAD1L1 (rat) KWQEANQKIQELQAS K207
S214-p
kIQELQAsQEARADH
Upstream
Downstream
2 5
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
  • protein conformation
Effects on Biological Processes:
  • DNA repair, induced
  • carcinogenesis, induced
  • cell cycle regulation
  • signaling pathway regulation
Kinase, in vitro:
  • ATM (human)
Putative in vivo kinases:
  • ATM (human)
Treatment
  • ionizing_radiation
  • siRNA
  • thymidine
MAD1L1 (human) kIQELQAsQEARADH S214-p
MAD1L1 (mouse) KIQELQASQDERAEH S214
MAD1L1 (rat) KIQELQASQEERTDQ S214
K231-ub
QIKDLEQkLsLQEQD
0 1
MAD1L1 (human) QIKDLEQkLsLQEQD K231-ub
MAD1L1 (mouse) KIKDLEQKLCLQEQD K231
MAD1L1 (rat) KIKDLEQKLCLQEQD K231
S233-p
KDLEQkLsLQEQDAA
0 1
MAD1L1 (human) KDLEQkLsLQEQDAA S233-p
MAD1L1 (mouse) KDLEQKLCLQEQDAA C233
MAD1L1 (rat) KDLEQKLCLQEQDAA C233
K313-ub
ENERLLAkLQSWERL
0 2
MAD1L1 (human) ENERLLAkLQSWERL K313-ub
MAD1L1 (mouse) EKEKLLAKLQSWENL K313
MAD1L1 (rat) EKEKLLAKLQSWEKL K313
T323-p
SWERLDQtMGLSIRT
Upstream
1 0
Kinase, in vitro:
  • TTK (human)
MAD1L1 (human) SWERLDQtMGLSIRT T323-p
MAD1L1 (mouse) SWENLDQTMGLNLRT T323
MAD1L1 (rat) SWEKLDQTMGLNLRT T323
K351-ub
RELALKDkNSAVTSS
0 1
MAD1L1 (human) RELALKDkNSAVTSS K351-ub
MAD1L1 (mouse) RELTLKEKNNSITSS K351
MAD1L1 (rat) RELALKEKNSSITSS K351
S377-p
QEELRQVsGQLLEER
0 2
MAD1L1 (human) QEELRQVsGQLLEER S377-p
MAD1L1 (mouse) QDEVRQANAQLLEER N377
MAD1L1 (rat) QDEVRQVNAQLLEER N377
K406-ub
KRVLLLTkERDGMRA
0 1
MAD1L1 (human) KRVLLLTkERDGMRA K406-ub
MAD1L1 (mouse) KRNALLTKERDGMRA K406
MAD1L1 (rat) KRNALLTKERDGMRA K406
T423-p
GSYDSELtPAEYsPQ
0 2
MAD1L1 (human) GSYDSELtPAEYsPQ T423-p
MAD1L1 (mouse) GSYDSELtQTEYSTQ T423-p
MAD1L1 (rat) GSYDSELTQAEYSPQ T423
S428-p
ELtPAEYsPQLtRRM
Upstream
1 29
Treatment
  • metastatic potential
  • MG132
  • MG132_withdrawal
  • nocodazole
  • thymidine
MAD1L1 (human) ELtPAEYsPQLtRRM S428-p
MAD1L1 (mouse) ELtQTEYSTQLTQRL S428
MAD1L1 (rat) ELTQAEYSPQLTQRM S428
T432-p
AEYsPQLtRRMREAE
0 1
MAD1L1 (human) AEYsPQLtRRMREAE T432-p
MAD1L1 (mouse) TEYSTQLTQRLWEAE T432
MAD1L1 (rat) AEYSPQLTQRMWEAE T432
K467-ub
LEELGGQkQRADMLE
0 1
MAD1L1 (human) LEELGGQkQRADMLE K467-ub
MAD1L1 (mouse) LEELGVQKQRADTLE K467
MAD1L1 (rat) LEELGVQKQRADTLE K467
K478-ac
DMLEMELkMLkSQss
0 1
MAD1L1 (human) DMLEMELkMLkSQss K478-ac
MAD1L1 (mouse) DTLEMELKMLKAQTS K478
MAD1L1 (rat) DTLEMELKMLRAQTS K478
K481-ub
EMELkMLkSQsssAE
0 2
MAD1L1 (human) EMELkMLkSQsssAE K481-ub
MAD1L1 (mouse) EMELKMLKAQTSSAE K481
MAD1L1 (rat) EMELKMLRAQTSSAE R481
S484-p
LkMLkSQsssAEQsF
0 1
MAD1L1 (human) LkMLkSQsssAEQsF S484-p
MAD1L1 (mouse) LKMLKAQTSSAESSF T484
MAD1L1 (rat) LKMLRAQTSSAEASF T484
S485-p
kMLkSQsssAEQsFL
0 1
MAD1L1 (human) kMLkSQsssAEQsFL S485-p
MAD1L1 (mouse) KMLKAQTSSAESSFS S485
MAD1L1 (rat) KMLRAQTSSAEASFP S485
S486-p
MLkSQsssAEQsFLF
0 1
MAD1L1 (human) MLkSQsssAEQsFLF S486-p
MAD1L1 (mouse) MLKAQTSSAESSFSF S486
MAD1L1 (rat) MLRAQTSSAEASFPF S486
S490-p
QsssAEQsFLFsREE
Upstream
0 5
Treatment
  • BI_4834
  • nocodazole
MAD1L1 (human) QsssAEQsFLFsREE S490-p
MAD1L1 (mouse) QTSSAESSFSFCKEE S490
MAD1L1 (rat) QTSSAEASFPFCKEE S490
S494-p
AEQsFLFsREEADtL
0 1
MAD1L1 (human) AEQsFLFsREEADtL S494-p
MAD1L1 (mouse) AESSFSFCKEEVDAL C494
MAD1L1 (rat) AEASFPFCKEEVDAL C494
T500-p
FsREEADtLRLkVEE
0 1
MAD1L1 (human) FsREEADtLRLkVEE T500-p
MAD1L1 (mouse) FCKEEVDALRLKVEE A500
MAD1L1 (rat) FCKEEVDALRLKVEE A500
K504-ub
EADtLRLkVEELEGE
0 3
MAD1L1 (human) EADtLRLkVEELEGE K504-ub
MAD1L1 (mouse) EVDALRLKVEELEGE K504
MAD1L1 (rat) EVDALRLKVEELEGE K504
S513-p
EELEGERsRLEEEKR
Upstream
0 3
Treatment
  • BI_4834
MAD1L1 (human) EELEGERsRLEEEKR S513-p
MAD1L1 (mouse) EELEGERSRLEQEKQ S513
MAD1L1 (rat) EELEGERSRLEQEKQ S513
Y535-p
RRALQGDyDQsRTKV
0 8
MAD1L1 (human) RRALQGDyDQsRTKV Y535-p
MAD1L1 (mouse) KLTLQGDYNQSRTKV Y535
MAD1L1 (rat) RLTLQGDYNQSRTKV Y535
S538-p
LQGDyDQsRTKVLHM
0 1
MAD1L1 (human) LQGDyDQsRTKVLHM S538-p
MAD1L1 (mouse) LQGDYNQSRTKVLHM S538
MAD1L1 (rat) LQGDYNQSRTKVLHM S538
S546-p
RTKVLHMsLNPTsVA
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell cycle regulation
  • cell growth, induced
  • chromatin organization, altered
Kinase, in vitro:
  • ULK1 (human)
Putative in vivo kinases:
  • ULK1 (human)
Treatment
  • siRNA
MAD1L1 (human) RTKVLHMsLNPTsVA S546-p
MAD1L1 (mouse) RTKVLHMSLNPISMA S546
MAD1L1 (rat) RTKVLHMSLNPASMA S546
S551-p
HMsLNPTsVARQRLR
Upstream
0 1
Treatment
  • hesperadin
  • MG132
  • nocodazole
MAD1L1 (human) HMsLNPTsVARQRLR S551-p
MAD1L1 (mouse) HMSLNPISMARQRQH S551
MAD1L1 (rat) HMSLNPASMARQRQR S551
S562-p
QRLREDHsQLQAECE
0 2
MAD1L1 (human) QRLREDHsQLQAECE S562-p
MAD1L1 (mouse) QRQHEDHDRLQEECE D562
MAD1L1 (rat) QRQREDHDRLQEECE D562
T583-p
RAMERGGtVPADLEA
0 1
MAD1L1 (human) RAMERGGtVPADLEA T583-p
MAD1L1 (mouse) HALERGGPIPADLEA P583
MAD1L1 (rat) HALERGGPIPADLEA P583
S597-p
AAAASLPsskEVAEL
0 1
MAD1L1 (human) AAAASLPsskEVAEL S597-p
MAD1L1 (mouse) EAASSLPSSKEVAEL S596
MAD1L1 (rat) EAASSLPSSKEVAEL S596
S598-p
AAASLPsskEVAELK
Upstream
Downstream
1 1
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • TTK (human)
MAD1L1 (human) AAASLPsskEVAELK S598-p
MAD1L1 (mouse) AASSLPSSKEVAELR S597
MAD1L1 (rat) AASSLPSSKEVAELR S597
K599-ub
AASLPsskEVAELKK
0 1
MAD1L1 (human) AASLPsskEVAELKK K599-ub
MAD1L1 (mouse) ASSLPSSKEVAELRK K598
MAD1L1 (rat) ASSLPSSKEVAELRK K598
S610-p
ELKKQVEsAELkNQR
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • TTK (human)
MAD1L1 (human) ELKKQVEsAELkNQR S610-p
MAD1L1 (mouse) ELRKQVESAELKNQR S609
MAD1L1 (rat) ELRKQVESAELKNQR S609
K614-ub
QVEsAELkNQRLkEV
0 3
MAD1L1 (human) QVEsAELkNQRLkEV K614-ub
MAD1L1 (mouse) QVESAELKNQRLKEV K613
MAD1L1 (rat) QVESAELKNQRLKEV K613
K619-ub
ELkNQRLkEVFQtkI
0 2
MAD1L1 (human) ELkNQRLkEVFQtkI K619-ub
MAD1L1 (mouse) ELKNQRLKEVFQTKI K618
MAD1L1 (rat) ELKNQRLKEVFQTKI K618
T624-p
RLkEVFQtkIQEFRK
Upstream
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • TTK (human)
MAD1L1 (human) RLkEVFQtkIQEFRK T624-p
MAD1L1 (mouse) RLKEVFQTKIQEFRK T623
MAD1L1 (rat) RLKEVFQTKIQEFRK T623
K625-ub
LkEVFQtkIQEFRKA
0 1
MAD1L1 (human) LkEVFQtkIQEFRKA K625-ub
MAD1L1 (mouse) LKEVFQTKIQEFRKV K624
MAD1L1 (rat) LKEVFQTKIQEFRKV K624
Y634-p
QEFRKACyTLTGYQI
Downstream
1 0
Effects on Biological Processes:
  • cell cycle regulation
MAD1L1 (human) QEFRKACyTLTGYQI Y634-p
MAD1L1 (mouse) QEFRKVCYTLTGYQI Y633
MAD1L1 (rat) QEFRKVCYTLTGYQI Y633
K674
ATSPSGSKMQLLEtE
0 1
MAD1L1 (human) ATSPSGSKMQLLEtE K674
MAD1L1 (mouse) ATGPSGSkMQLLETE K673-ub
MAD1L1 (rat) ATGPSGSKMQLLETE K673
T680-p
SKMQLLEtEFSHTVG
Upstream
Downstream
1 1
Effects on Modified Protein
  • activity, induced
  • intracellular localization
Effects on Biological Processes:
  • cell cycle regulation
Putative in vivo kinases:
  • PLK1 (human)
MAD1L1 (human) SKMQLLEtEFSHTVG T680-p
MAD1L1 (mouse) SkMQLLETEFSRSVP T679
MAD1L1 (rat) SKMQLLETEFSRSVP T679
S699-p
VHLRRQDsIPAFLSS
1 1
MAD1L1 (human) VHLRRQDsIPAFLSS S699-p
MAD1L1 (mouse) LHLLQQDSIPAFLSA S698
MAD1L1 (rat) LHLLQQDSIPAFLSA S698
T708-p
PAFLSSLtLELFSRQ
Downstream
1 1
Effects on Modified Protein
  • intracellular localization
MAD1L1 (human) PAFLSSLtLELFSRQ T708-p
MAD1L1 (mouse) PAFLSALTIELFSRQ T707
MAD1L1 (rat) PAFLSALTIELFSRQ T707
T716-p
LELFSRQtVA_____
Upstream
Downstream
2 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • cell cycle regulation
Kinase, in vitro:
  • TTK (human)
Putative in vivo kinases:
  • TTK (human)
Treatment
  • AZ3146
  • reversine
MAD1L1 (human) LELFSRQtVA_____ T716-p
MAD1L1 (mouse) IELFSRQTSI_____ T715
MAD1L1 (rat) IELFSRQTSV_____ T715